Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups Results From the Randomized CREDENCE Trial

Mahaffey Kenneth W. and Jardine Meg J. and Bompoint Severine and Cannon Christopher P. and Neal Bruce and Heerspink Hiddo J.L. and Charytan David M. and Edwards Robert and Agarwal Rajiv and Bakris George and Bull Scott and Kollaborációs szervezet: REDENCE Study Investigators and Keltai Katalin and Takács Róbert and et al. (kollab. közrem.): Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups Results From the Randomized CREDENCE Trial.
CIRCULATION, 140 (9). pp. 739-750. ISSN 0009-7322 (2019)

[thumbnail of Mahaffey.pdf]
Preview
Text
Mahaffey.pdf - Published Version

Download (501kB) | Preview
Item Type: Journal Article
Szerzők száma: 862
Journal or Publication Title: CIRCULATION
Date: 2019
Volume: 140
Number: 9
Page Range: pp. 739-750
ISSN: 0009-7322
Faculty/Unit: Albert Szent-Györgyi Medical School
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 31086950
DOI azonosító: https://doi.org/10.1161/CIRCULATIONAHA.119.042007
Date Deposited: 2023. Mar. 03. 10:24
Last Modified: 2023. Mar. 03. 10:24
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/26652
Web of Science® Times Cited: 183 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year